Bullish
$LJPC Even without Covid-19, Giapreza should have peak sales at least around 300-400 million in few years. That would have taken some years to materialize but due to Covid-19, they will approach that level much sooner. Covid-19 causes a huge ramp up on sales and at the same time it quickly causes the product to become a part of standard of care. These current unfortunate events around the world are actually the best marketing campaign ever for the company and the product. And at the same time they are saving lives.
  • 6
  • 1